Photodynamic therapy in the treatment of condyloma acuminata: A systematic review of clinical trials

Int J STD AIDS. 2023 Feb;34(2):76-86. doi: 10.1177/09564624221138351. Epub 2022 Nov 24.

Abstract

Introduction: Condylomata acuminata (CA) is a sexually transmitted infection with a high prevalence associated with psychosexual morbidity in both men and women of various age. Up to now, treatment modalities yield low clearance and recurrence rate (RR) and are also deemed low quality evidence-wise. Photodynamic therapy (PDT) is a novel and promising therapy to effectively cure and prevent CA recurrence.

Method: This systematic review was reported according to the Preferred Reporting Items for Systematic Review and Meta-Analysis (PRISMA) and registered to the International Prospective Register of Systematic Review (PROSPERO) (CRD42022332760).

Results: Ten studies were included in this systematic review. A significant value of complete response (CR) ranging from 63-100% in patients with genital warts after receiving several sessions of PDT. A relatively low recurrence rate was seen in all 10 studies, with an RR of less than 17%. Quality assessment of included studies reported mostly high-quality research.

Conclusions: PDT therapy resulted in a higher CR with significantly lower RR compared to other therapies. Thus, PDT can be an alternative treatment of CA with low RR and minimal side effects. Additional research, especially randomized clinical trials in various countries, is needed to further substantiate this treatment and formulate definitive protocols.

Keywords: Genital warts; condylomata acuminata; photodynamic therapy; systematic review.

Publication types

  • Review
  • Systematic Review

MeSH terms

  • Clinical Trials as Topic
  • Condylomata Acuminata* / drug therapy
  • Female
  • Humans
  • Male
  • Photochemotherapy* / methods